Safety Profile Comparison (2026 Data) Risk Factor Semaglutide (GLP-1) Bariatric Surgery Invasiveness Non-invasive (Injection) Invasive (Surgery) Common Risks Nausea, Vomiting, Constipation Infection, Bleeding, Blood Clots Serious Risks Pancreatitis, Gastroparesis Dumping Syndrome, Malnutrition Anesthesia Risk None Standard Surgical Risk Reversibility Fully Reversible Generally Permanent 2
Medical Providers: This is the most important factor
"A lot of people [might have] bypassed their insurance to go for these compounded versions," Kaylor mentioned
Metabolic Complications: Women with PCOS are at increased risk for type 2 diabetes, obesity, and cardiovascular disease due to insulin resistance
NAD+ itself is not a peptide, so at Perfect B we keep true NAD+ therapy separate from peptide therapy and explain exactly what each one is during your consultation
Payers especially dont want to be paying for somebody to be on a lifetime of medication, said Alex Lennox-Miller, a health care and life sciences analyst at SVB